Affirm Holdings, Inc. – Consensus ‘hold’ rating and 22.8% Upside Potential

DirectorsTalk Interviews

Affirm Holdings, Inc. which can be found using ticker (AFRM) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $65.00 and $20.00 calculating the mean target price we have $36.87. Given that the stocks previous close was at $30.03 this now indicates there is a potential upside of 22.8%. The 50 day moving average now sits at $33.30 and the 200 day moving average is $31.40. The company has a market capitalization of 9.16B. The current stock price for Playtika Holding Corp. is currently $29.64 USD

The potential market cap would be $11,249,419,151 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of -, revenue per share of $6.90 and a -5.8% return on assets.

Affirm Holdings, Inc. provides a platform for digital and mobile-first commerce. The Company’s platform comprises three elements: point-of-sale payment solutions for consumers, merchant commerce solutions, and a consumer-focused app. Its point-of-sale solutions allow consumers to pay for purchases in fixed amounts without deferred interest, late fees, or penalties. Its merchant commerce solutions offer commerce enablement, demand generation, and customer acquisition tools. Its consumer-focused app provides Affirm products, which consumers can use to manage payments, open a high-yield savings account, and access a personalized marketplace. The Company’s platform provides consumer and merchant features. Its consumer features include checkout, consumer borrowing, virtual card, affirm app and marketplace and Affirm debit+ card. Its merchant features include affirm at Checkout, merchant dashboard, analytics, client success support, affirm app, and returns management, among others.

Share on:

Latest Company News

Diversified Energy gains recognition for sustainability focus

Diversified Energy shortlisted for US IR award recognising ESG alignment and responsible investor engagement.

Dunelm reports solid H1 FY26 sales growth amid challenging market conditions

Dunelm Group plc announced Interim Results for the 26 weeks to 27 December 2025, reporting total sales growth of 3.6% to £926.3m and increased market share despite a softer second quarter.

Bellway reports higher completions and maintains FY26 guidance

Bellway said first-half housing completions rose to 4,702 homes, with revenue up over 6% to £1.51bn, despite softer reservation rates through the autumn.

Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)

Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world use—and why clinicians and payers are getting on board.

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International.

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress.

    Search

    Search